Differences
This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revisionBoth sides next revision | ||
helene_decaluwe [2022/05/22 15:31] liam | helene_decaluwe [2022/09/20 03:45] (current) liam [COVID-19] | ||
---|---|---|---|
Line 20: | Line 20: | ||
Decaluwe is a member of the [[National Advisory Committee on Immunization]] (NACI).((Public Health Agency of Canada. (2022, February 25). //National Advisory Committee on Immunization (NACI): Membership and representation.// | Decaluwe is a member of the [[National Advisory Committee on Immunization]] (NACI).((Public Health Agency of Canada. (2022, February 25). //National Advisory Committee on Immunization (NACI): Membership and representation.// | ||
+ | |||
+ | ===== Consulting ===== | ||
+ | |||
+ | Decaluwe was invited in April 2021 by [[pharmaceutical_companies: | ||
===== Research ===== | ===== Research ===== | ||
Line 47: | Line 51: | ||
=== CHOIR === | === CHOIR === | ||
- | Decaluwe is a Principal Investigator]] in the Children and Older Teens Immune Response to SARS-CoV-2 in Montreal ([[CHOIR study]]) alongside [[Caroline Quach-Thanh]] and [[Jesse Papenburg]], | + | Decaluwe is a Principal Investigator in the Children and Older Teens Immune Response to SARS-CoV-2 in Montreal ([[CHOIR study]]) alongside [[Caroline Quach-Thanh]] and [[Jesse Papenburg]], |
+ | |||
+ | ===== Presentations ===== | ||
+ | |||
+ | Decaluwe presented at the 76th Annual [[Canadian Society of Allergy and Clinical Immunology]] Scientific Virtual Meeting on the topic of hyperinflammation and targeted immunotherapies in hemophagocytic lymphohistiocytosis.((// |